πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. The gold coating on a USP Dissolution apparatus - I basket should be:
  • (A) Not more than 2.5 m in thickness
  • (B) Not more than 0.1 mm in thickness
  • (C) Not more than 0.025 m in thickness
  • (D) Not more than 0.22 mm in thickness
πŸ’¬ Discuss
βœ… Correct Answer: (A) Not more than 2.5 m in thickness
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. In vitro dissolution rate studies on drug product are useful in bioavailability evaluation if they are correlated with
  • (A) Disintegration rate
  • (B) In vivo studies in at least 3 species of animals
  • (C) Chemical stability of drugs
  • (D) In vivo studies in human
πŸ’¬ Discuss
βœ… Correct Answer: (D) In vivo studies in human
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. ………………is the ratio of the mean residence time to the absorption time
  • (A) Absorption number
  • (B) Dissolution number
  • (C) Dose number
  • (D) Intrinsic dissolution
πŸ’¬ Discuss
βœ… Correct Answer: (A) Absorption number
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. According to Biopharmaceutics Classification System (BCS), Class II drugs have
  • (A) High solubility/High permeability
  • (B) Low solubility /High permeability
  • (C) High solubility /Low permeability
  • (D) Low solubility /Low permeability
πŸ’¬ Discuss
βœ… Correct Answer: (B) Low solubility /High permeability
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. What is the driving force for glomerular filtration?
  • (A) Concentration gradient
  • (B) Hydrostatic pressure of plasma
  • (C) High amount of aqueous pores
  • (D) Hydrostatic pressure of blood flow
πŸ’¬ Discuss
βœ… Correct Answer: (D) Hydrostatic pressure of blood flow
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Biotransformation of a medicinal substance results in:
  • (A) Slower urinary excretion
  • (B) Faster urinary excretion
  • (C) Higher binding to membranes
  • (D) Easier distribution in organism
πŸ’¬ Discuss
βœ… Correct Answer: (B) Faster urinary excretion
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. For the calculation of the volume of distribution (Vd) one take into account:
  • (A) Concentration of a substance in urine
  • (B) Concentration of substance in plasma
  • (C) A daily dose of drug
  • (D) Therapeutic width of drug action
πŸ’¬ Discuss
βœ… Correct Answer: (B) Concentration of substance in plasma
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. The term "biotransformation" includes the following.
  • (A) Accumulation of substances in a fat tissue
  • (B) Process of physicochemical and biochemical alteration of a drug in the body
  • (C) Binding of substances with plasma proteins
  • (D) Accumulation of substances in a tissue
πŸ’¬ Discuss
βœ… Correct Answer: (B) Process of physicochemical and biochemical alteration of a drug in the body